Company information:
Gammadelta Therapeutics Ltd (No: 10238425)
Address: 1 KINGDOM STREET, LONDON, W2 6BD, ENGLAND
Status: Active
Incorporated: 17-Jun-2016
Accounts Next Due: 31-Mar-2024
Next Confirmation Statement Due: 30-Jun-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: DANIEL MATTHEW KEMP ( DOB: Oct-1973 From: May-2017 )
Current Director: SEYDA ATADAN MEMIS ( DOB: Mar-1979 From: Aug-2022 )
Current Director: SEYDA ATADAN MEMIS ( DOB: Mar-1979 From: Aug-2022 )
Current Director: SEYDA ATADAN MEMIS ( DOB: Mar-1979 From: Aug-2022 )
Current Director: JONATHAN CLARK NEAL ( DOB: Aug-1971 From: Apr-2022 )
Current Director: EMMA JANE ROFFE ( DOB: Mar-1972 From: Apr-2022 )
Current Secretary: BRYAN DRISCOLL ( From: Apr-2022 )
Resigned Director: MARK GIBBONS ( DOB: Jan-1984 From: Apr-2022 To: Nov-2022 )
Resigned Director: PETER NEVILLE GOODFELLOW ( DOB: Aug-1951 From: Aug-2016 To: Apr-2022 )
Resigned Director: TIMOTHY JOHN HAINES ( DOB: Aug-1957 From: Sep-2016 To: Apr-2022 )
Resigned Director: TIMOTHY JOHN HAINES ( DOB: Aug-1957 From: Sep-2016 To: Apr-2022 )
Resigned Director: ADRIAN CLIVE HAYDAY ( DOB: Apr-1956 From: Aug-2016 To: Apr-2022 )
Resigned Director: HEATHER ADKINS HUET ( DOB: Jan-1971 From: Apr-2021 To: Jul-2022 )
Resigned Director: RAJ MEHTA ( DOB: May-1968 From: Jun-2016 To: Feb-2017 )
Resigned Director: JONATHAN CLARK NEAL ( DOB: Aug-1971 From: Apr-2022 To: Jan-2023 )
Resigned Director: MICHAEL JOHN OWEN ( DOB: May-1951 From: Aug-2016 To: Apr-2022 )
Resigned Director: PAOLO PAOLETTI ( DOB: Oct-1950 From: Feb-2017 To: Apr-2022 )
Resigned Director: STEPHEN BARRY PARKER ( From: Sep-2016 To: Jun-2017 )
Resigned Director: JOHN GERARD SHIELDS ( DOB: Mar-1955 From: Aug-2016 To: Sep-2016 )
Persons of Significant Control:
Abingworth Llp, 1-1 Doshomachi 4-Chome Doshomachi 4-Chome, Chuo-Ku, Osaka, 12-10, Japan: Ownership of shares – More than 25% but not more than 50%, Ownership of shares – More than 25% but not more than 50% as a trustee of a trust, Right to appoint and remove directors (Notified: 2016-08-15, Ceased: 2017-07-24)
Abingworth Bioventures Vi Gp Lp, 50 Lothian Road, Festival Square, Edinburgh, Midlothian, EH3 9WJ, Scotland: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50%, Right to appoint and remove directors (Notified: 2017-07-24, Ceased: 2022-04-05)
Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-Chome Doshomachi 4-Chome, Chuo-Ku, Osaka, 12-10, Japan: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2017-05-08)